by Richard Daverman, PhDApril 29, 2013 -- Shanghai Fosun Pharma, Chindex and a private equity partner will spend up to $240 million to buy 95.6% of an Israeli medical device company,
Alma Lasers. Alma, which had revenues of about $100 million last year, ...
[Published BioSpace - Apr 30 2013]